| Actual |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Legal > Patents > Patent History, Part I |
|
Actual - Patent History, Part I
You are about to learn a brief history of patents and how they become to be so essential in busin According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ess as we know it. The first written mention of modern patents we know of are in 15th century bu ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in siness documents from Italy. Italy was one of the first countries to make it possible for an inve lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. stor to protect an idea by obtaining government or official recognition of the creative act. This here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe early experiment in intellectual property rights led to a ferment of growth and discovery in Ital d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro y and elsewhere. After Italy issued the first set of patents, their use did not widely spread to ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc neighboring European countries until the 17th century. From there, the concept of patents in the easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi United States was first recognized in the Patent Act of 1790, which consisted of a brief collect nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically on of patent rules and guidelines on how to obtain a patent. Under the Patent Act, different memb and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ers of the government were given the ability to grant a patent. For example, both the Secretary o ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi f State and the Attorney General were legally allowed to approve patents. However, as a result o ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a f the influence of Thomas Jefferson, and complaints by the general public, the 1790 Patent Act wa dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod changed in 1793 to encompass a broader set of standards and rules. The revised Act allowed inven cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin tors to obtain patents for machines, substances of matter, or objects of art. However, unlike the tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen patent applications of the current day, these early patent applications required only a brief de t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel scription of the item the inventor was requesting a patent for. As time passed, inadequacies in ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust he patent structure became apparent. The governing body responsible for patents at that time real y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ized that with the increase in the amount of foreign nationals moving to the United States, the P . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de atent Act needed to allow foreign inventors the right to apply and obtain patents. Applicants wer elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e required to reside in the United States for at least two years before submitting an application tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Agro Textiles: A Novel Application E-Newsletters, The Best & Worst Internet Marketing Tools Instant Personal Loans: Swift Service - Round The Clock
|